The global cerebral spinal fluid management market is expected to witness moderate growth in the coming years.
The growth is
predicted to be at a CAGR of 5.3% between 2021 to 2028, the market is expected
to reach the valuation of USD 2.61bn by the end of 2028.
Researchmoz
throws some light on the global cerebral spinal fluid management market
including market size, drivers, restraints, trends, opportunities, market
segmentation, and competitive landscape.
Lately, there
has been a rise in the number of brain surgeries, globally, the increase in
such surgeries is paving the way for the expansion of the global cerebral
spinal fluid management market.
With the onset
of the covid-19 pandemic, the market went through a dull period as surgeries
had to be delayed and covid treatment was put on high priority.
As the world is
regaining its grip on the economies, the global cerebral spinal fluid market is
finding its place back in the medical sector.
Factors Driving and Restraining the Market
Some of the determinants that drive the global cerebral spinal
fluid management market are-
- Increasing cases of meningitis are
anticipated to boost the market for cerebral spinal fluid, owing to its
use in the diagnosis of meningitis.
- The growing geriatric population and
neurovascular disorders associated with old age are projected to expand
cerebral spinal fluid management during the forecast period.
- Increasing cases of congenital
hydrocephalus among babies are expected to amplify growth in the global
cerebral spinal fluid management market in the next few years.
- The rising cases of brain tumours across
the globe are expected to drive the demand for cerebral spinal fluid
management.
- The increasing investments in research and
development in the area of cerebral spinal fluid management is likely to
push the growth in the market.
- The grants especially for research in
neuromodulation therapies and cure is anticipated to stimulate the expansion
of the cerebral spinal fluid management market.
There are certain challenges in the global cerebral spinal fluid
management market which may act as restraints during the forecast period.
- The lack of trained professionals to
handle cerebral spinal fluid devices may hinder the growth of the market.
- Further, the fear of side effects and the
high cost of such surgeries is expected to hamper the expansion of the
cerebral spinal fluid management market in the forecast period.
However, the
increasing cases of rhinosinusitis with nasal polyps is expected to navigate
the cerebral spinal fluid management market to swell up in the near future.
Analyst’s Views
- The global cerebral spinal fluid
management market is predicted to grow steadily, registering a growth a CAGR
of 5.3% during the forecast period 2021 to 2028.
- The innovation and technology to stimulate
the market expansion in the coming years.
- Novel molecular and cellular biology
insights are challenging the traditional concepts of cerebral spinal
fluid, thus leading to amplification of the global cerebral spinal fluid
management market during the forecast period.
- Antinuclear antibodies in the geriatric
population could lead to intensified demand for cerebral spinal fluid in
the coming years.
- The market is evolving back from the
negative impacts of covid and is set to thrive back in the medical sector.
- The shunt segment is expected to witness
high sales in the global cerebral spinal fluid management market, owing to
its ability to take out excess fluid from the brain and pass it on to the
abdomen, so that it gets absorbed in the abdomen.
- Further, due to rising cases of congenital
hydrocephalus in infants, the paediatric segment is expected to bolster
the demand for cerebral spinal fluid management during the forecast years.
- The major share in the market is likely to
be held by the Asia Pacific, owing to the rising population, growing
geriatric population, better healthcare infrastructure, and increasing
medical tourism.
Competitive Landscape
The presence of
many players in the market makes the global cerebral spinal fluid management
competitive.
The major players
in the market are busy strategizing on business expansion, innovative product
launches, collaborations, mergers, and acquisitions to amplify the market
position, profitability, and business portfolio.
The major players in the global cerebral spinal fluid management
are-
- Spiegelberg
- Integra Life Sciences
- Sophysa
- BeckerSmith Medical
- Dispomedica
- DePuy Synthes Companies (Johnson &
Johnson)
- BeckerSmith Medical
Get
Free Research PDF Of The Report: https://www.researchmoz.us/request-free-sample/?reportid=683
No comments:
Post a Comment